Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Minimal residual disease in acute lymphoblastic leukemia: a new concept of complete remission].

Anales de pediatria (Barcelona, Spain : 2003) - 1 Nov 2005

Bastida Vilá P, Palacio García C, Solsona Riera M, Ortega Aramburu J J, Sánchez de Toledo Codina J

Abstract excerpt

INTRODUCTION: Early response to induction treatment is one of the most important prognostic factors in children with acute lymphoblastic leukemia (ALL). Cytological remission is currently achieved in 95-98 % of these patients, although a significant proportion will later relapse. More sensitive techniques are required to measure residual leukemia and establish a new definition of complete remission. OBJECTIVE: To...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Infant

Share to Neoplasm, Residual

Share to Phenotype

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Remission Induction

Source

Identifiers

PMID: 16266612
DOI: 10.1157/13080401

Genes

EFS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Minimal residual disease in acute lymphoblastic leukemia: a new concept of complete remission].PMID 16266612Read ↗

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical AdvancesSemantic proximity Read ↗

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesSemantic proximity Read ↗

Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Detection and management of minimal residual disease in acute lymphoblastic leukemiaSemantic proximity Read ↗

Detection of minimal residual disease in acute myelogenous leukemia.Semantic proximity Read ↗

Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patientSemantic proximity Read ↗

[Prognostic value of residual disease detection in acute myeloid leukemia with normal karyotype and negative FLT3-ITD].Semantic proximity Read ↗

Detection of minimal residual disease in pediatric acute lymphoblastic leukemiaSemantic proximity Read ↗

Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.Semantic proximity Read ↗

Detection of minimal residual disease in leukemias: a critical approach.Semantic proximity Read ↗

Presence of minimal residual disease determined by next-generation sequencing is not a reliable prognostic biomarker in children with acute lymphoblastic leukemiaSemantic proximity Read ↗

Minimal residual disease in acute myeloid leukemia: coming of age.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.